Scientists at BC Children's Hospital and the University of British Columbia have developed a gene therapy that programs a type of immune cell called T regulatory cells (Tregs) to protect transplanted tissues from rejection by the patient's immune system. The proof-of-concept study is published today in the Journal of Clinical Investigation print issue.
↧